Factors that delay malaria diagnosis and treatment in the municipality of Riberalta in Bolivia
Abstract
Introduction. Few studies on the causes of the delay of malaria diagnosis and treatment in Bolivia are published.Objective. To know the factors that delay malaria diagnosis and treatment of malaria in the public service of the town of Riberalta, Bolivia.
Materials and methods. The times between the onset of symptoms and treatment, between the onset of symptoms and diagnosis and between the diagnosis and the start of treatment were calculated. The averages of the calculated times were compared with respect to the site of infection, parasite species, level of care, place of diagnosis and diagnostic method and th patient’s age was correlated with the calculated times.
Results. Between January and December 2010, 2,482 positive valid cases were studied. An average of 4.16 days was found between the onset of symptoms and the start of treatment, the average time between the onset of symptoms and diagnosis was 4.07 days, and between diagnosis and the start of treatment 0.10 days. Statistically significant (p<0.05) differences were found for factors related to the delay of diagnosis such as place of diagnosis, site of infection, level of care, parasite species and diagnostic method. The analysis of covariance showed a statistical association with the level of care and the parasite species (p<0.05).
Conclusion. The delay in malaria diagnosis is influenced by factors such as the site of infection, place of diagnosis, level of care, parasite species and diagnostic method.
Downloads
References
World Health Organization. World Malaria Report 2009. Geneva: WHO; 2009. Fecha de consulta: 29 de marzo de 2011. Disponible en: http://www.who.int/malaria/world_malaria_report_2009/en/index.html.
World Health Organization. Malaria case management: Operation manual. Geneva: WHO; 2009. p. 55-65.
White JN. The role of anti-malarial drugs in eliminating malaria. Malar J. 2008;7:S8.
Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg.1999;60:1019-23.
Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. The puberty of P. falciparum. Malar J. 2004;14:3-24.
Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of P. vivax malaria. Am J Trop Med Hyg. 2001;64:S97-106.
Mckenzie F, Jeffery G, Collins W. P. vivax blood-stage dynamics. J Parasitol. 2002;88:521-35.
Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24:377-410.
Engwerda C, Belnoue E, Grüner AC, Rénia L. Experimental model of cerebral en malaria. Curr Top Microbiol Immunol. 2005;297:103-43.
Collins WE, Jeffery GM. Retrospective examination of mosquito infection on humans infected with P. falciparum. Am J Trop Med Hyg. 2003;68:366-71.
Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA. The epidemiology of P. falciparum gametocytes: Weapons of mass dispersion. Trends Parasitol. 2006;22:424-30.
Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996;347:1654-8.
Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, et al. Artesunate reduces but does not prevent post-treatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001;183:1254-9.
Hommel M. Towards a research agenda for global malaria elimination. Malar J. 2008;7(Suppl.1):S1.
Kokwaro G. Ongoing challenges in the management of malaria. Malar J. 2009;8(Suppl.1):S2.
Global Malaria Programme. Malaria elimination: A field manual for low and moderate endemic countries. Geneva: WHO; 2007.
Hacer Retroceder la Malaria y Socios. Guía de monitoreo y evaluación VIH-sida, tuberculosis y malaria. Second edition. Ginebra; 2003. Fecha de consulta: 29 de marzo de 2011. Disponible en: http://www.theglobalfund.org/documents/me/M_E_Toolkit_es.pdf.
Organización Mundial de la Salud, Departamento Hacer Retroceder la Malaria. Malaria control today. Current WHO Recommendations. Working Document. Ginebra, 2005. p. 65. Fecha de consulta: 29 de marzo de 2011. Disponible en: http://www.who.int/malaria/docs/MCT_workingpaper.pdf.
Roll Back Malaria Partnership. Guidelines for core population-based indicators 2009. RBM/WG/2009/TP.1. Geneva: WHO; 2009. Fecha de consulta: 29 de marzo de 2011. Disponible en: http://www.rollbackmalaria.org/partnership/wg/wg_monitoring/docs/GuidelinesForCorePopulationFINAL9-20_Malaria.pdf.
World Health Organization. The African Summit on Roll Back Malaria. WHO/CDS/RBM/2000.17. Geneva: WHO; 2000.
Bedoya GE, Bedoya SA. Enganche y servidumbre por deudas en Bolivia. Oficina Internacional del Trabajo. Ginebra: OIT; 2005. p. 21-43.
Organización Panamericana de la Salud. Informe de la situación del paludismo en las Américas, 2008. Washington, D.C.: OPS; 2010. p. 31-2 y 72-8.
World Health Organization. Treatment of uncomplicated P. falciparum malaria en: Guidelines for the treatment of malaria. NLM classification: WC 770. Second edition. Geneve: WHO; 2010. p. 13-32.
Price RN, Tjitra E, Guerra CA, Yeung S, White JN, Anstey MN. Vivax malaria neglected and not benign. Am J Trop Med Hyg. 2007;77:79-87.
Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, et al. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malar J. 2011;10:212.
Gama BE, Lacerda MV, Daniel-Ribeiro CT, Ferreira-da-Cruz M de F. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control. Mem Inst Oswaldo Cruz. 2011;106:159-66.
Giao PT, Vries PJ, Binh TQ, Nam NV, Kager PA. Early diagnosis and treatment of uncomplicated malaria and patterns of health seeking in Vietnam. Trop Med Int Health. 2005;10:919-25.
Organización Panamericana de la Salud. Plan estratégicoregional contra la malaria en las Américas 2006-2010. Washington, D.C.: OPS; 2006. p. 27-9.
Parks W, Lloyd L. Planificación de la movilización y comunicación social para la prevención y el control del dengue, guía paso a paso. Ginebra: OMS; 2004. p. 5-11.
Some similar items:
- Iveth J. González, Metacaspases and their role in the life cycle of human protozoan parasites , Biomedica: Vol. 29 No. 3 (2009)
- Astrid Elena Montoya, José Menco, Natalia Osorio, Maria Alejandra Zuluaga, Juliana Duque, Giovanny Torres, Marcos Restrepo, Concordance between thick blood smear, immunochromatography and polymerase chain reaction for malaria diagnosis , Biomedica: Vol. 28 No. 2 (2008)
- Pablo Chaparro, Edison Soto, Julio Padilla, Daniel Vargas, Estimation of the underreporting of malaria measurement in ten municipalities of the Pacific coast of Nariño during 2009 , Biomedica: Vol. 32 (2012): Suplemento 1, Malaria
- Eliana P. Calvo, María O. Rojas, Jacqueline Chaparro, Moisés Wasserman, Expresion of the multiple drug resistance associated gene (pfMDR 1) in Colombian strains of Plasmodium falciparum , Biomedica: Vol. 19 No. 3 (1999)
- César Segura, Silvia Blair, Mitochondria in the Plasmodium genera. , Biomedica: Vol. 23 No. 3 (2003)
- Jorge Alonso Marín, Mayra Alexandra Ortega, Isaura Pilar Sánchez, José Armando Pacheco, Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report , Biomedica: Vol. 37 No. 2 (2017)
- Carolina Montoya, Priscila Bascuñán, Julián Rodríguez-Zabala, Margarita M. Correa, Abundance, composition and natural infection of Anopheles mosquitoes from two malaria-endemic regions of Colombia , Biomedica: Vol. 37 No. Sup. 2 (2017): Suplemento 2, Entomología médica, 2017
- Juan Sergio Mollinedo, Zoraida Mollinedo , Marcelo Magne , Wilson J. Gironda, Óscar D. Salomón , Leishmaniasis en Bolivia. Comprehensive review and current status in Tarija, in the border with Argentina , Biomedica: Vol. 40 No. Supl. 1 (2020): Mayo, Infecciones en el trópico
- Nancy Arróspide, Hernán Sanabria, William J. Araujo-Banchon, Evaluation of the effectiveness of the OptiMAL-IT™ rapid test in the follow up of patients diagnosed with malaria in the Peruvian Amazon , Biomedica: Vol. 42 No. 1 (2022)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
